All Primary Antibodies

All Primary Antibodies
Primary antibodies, immunoglobulins that bind to specific proteins or other biomolecules, are used in many research applications and protocols to detect targets of interest. They are developed using different animal hosts, including mouse, rat, rabbit, goat, sheep, and many others.
Monoclonal and Polyclonal Antibodies
One type of primary antibodies, monoclonal antibodies, provides high reproducibility and low cross-reactivity and background noise. Another type, polyclonal antibodies, often costs less and provides greater affinity and quicker binding. Both are produced using plasma B cells, but the former uses the same clone and the latter uses different clones. Monoclonal antibodies require hybridoma cell lines, and polyclonal antibodies do not.
There are also recombinant monoclonal antibodies with similar benefits, like high affinity, scalability, and specificity. They are produced using in vitro cloning of plasma B cells and expression hosts.
Conjugated Primary Antibodies
Antibodies can be labeled with various fluorophores or detection agents or used without labels. Labeled primary antibodies, also known as conjugated primary antibodies, help researchers simplify and streamline their applications. They are coupled with common enzymes and dyes such as Alexa Fluor and often used in protein and cell analysis.
Applications
Antibodies for life sciences applications are used in flow cytometry, western blotting, ELISA, immunohistochemistry, and immunocytochemistry. Secondary antibodies can be added to support the detection and purification of certain antigens. They bind to the primary antibody, which binds to the antigen of interest. Finding the right combination of antibodies can result in greater antigen specificity and a strong, detectable signal.
- (4)
- (6)
- (2)
- (2)
- (5)
- (3)
- (2)
- (55)
- (23)
- (655)
- (827)
- (1)
- (1,025)
- (38)
- (1)
- (225)
- (1)
- (1)
- (59)
- (66,649)
- (26,537)
- (34)
- (3,852)
- (2,852)
- (322)
- (1)
- (3)
- (6)
- (13)
- (2)
- (1)
- (108)
- (3)
- (2)
- (1)
- (1)
- (2)
- (104)
- (170)
- (3)
- (2)
- (4,128)
- (53)
- (1)
- (1)
- (1,951)
- (1,850)
- (9)
- (50)
- (2)
- (2)
- (147)
- (2,762)
- (1,720)
- (26)
- (79)
- (40)
- (253)
- (1)
- (1)
- (3)
- (1)
- (2)
- (1)
- (29)
- (1)
- (3,099)
- (3)
- (1)
- (5)
- (1)
- (1)
- (12)
- (2)
- (2,300)
- (2)
- (13)
- (2)
- (1)
- (1)
- (7)
- (83)
- (1,992)
- (4,661)
- (27)
- (17)
- (8)
- (175)
- (979)
- (1)
- (1,093)
- (1)
- (2)
- (2)
- (19)
- (1)
- (37)
- (1)
- (1)
- (2)
- (3)
- (1)
- (1)
- (1,415)
- (4)
- (2)
- (33)
- (225)
- (10)
- (5)
- (4)
- (438)
- (3)
- (62)
- (44)
- (46)
- (8)
- (137)
- (1)
- (3)
- (70)
- (169)
- (17)
- (17)
- (15)
- (25)
- (3)
- (8)
- (1)
- (1)
- (1)
- (1)
- (1,811)
- (109)
- (62)
- (76)
- (94)
- (86)
- (155)
- (121)
- (125)
- (104)
- (72)
- (100)
- (100)
- (79)
- (1)
- (16)
- (1)
- (74)
- (52)
- (1)
- (57)
- (2)
- (1)
- (8)
- (5)
- (1,890)
- (558)
- (268)
- (2)
- (1)
- (97)
- (11)
- (19)
- (56)
- (28)
- (118)
- (149)
- (25)
- (80)
- (4)
- (22)
- (4)
- (10)
- (59)
- (69)
- (85)
- (76)
- (72)
- (4)
- (4)
- (4)
- (49)
- (51)
- (97)
- (112)
- (37)
- (54)
- (63)
- (68)
- (4)
- (1,971)
- (2)
- (3)
- (1)
- (136)
- (55)
- (569)
- (10)
- (171)
- (24)
- (14)
- (269)
- (146)
- (495)
- (1)
- (12)
- (13)
- (5)
- (6)
- (2)
- (2)
- (7)
- (5)
- (1)
- (168)
- (141)
- (50)
- (72)
- (63)
- (7)
- (5)
- (8)
- (3)
- (10)
- (2)
- (62)
- (1)
- (115,596)
- (19)
- (2)
- (362)
- (66)
- (46)
- (22)
- (269)
- (63)
- (41,527)
- (2)
- (3)
- (83,976)
- (5,360)
- (243)
- (3)
- (840)
- (1)
- (7)
- (252)
- (1)
- (2)
- (1)
- (3)
- (3,603)
- (47)
- (8)
- (675)
- (40)
- (7)
- (35,011)
- (1)
- (84,789)
- (5,499)
- (1)
- (255)
- (128)
- (39)
- (23)
- (2)
- (4)
- (12)
- (1)
- (1,030)
- (138)
- (3)
- (55)
- (1)
- (12)
- (2)
- (523)
- (3)
- (19,232)
- (21)
- (14)
- (24,618)
- (1)
- (3)
- (1,339)
- (1)
- (84)
- (8)
- (1)
- (34)
- (14)
- (41,240)
- (16)
- (16)
- (2,891)
- (23,405)
- (2)
- (35)
- (2,852)
- (935)
- (36,182)
- (105)
- (12,241)
- (1)
- (49)
- (6)
- (101)
- (33)
- (498)
- (45)
- (101)
- (217)
- (57)
- (34)
- (5)
- (138)
- (31)
- (641)
- (2)
- (69)
- (3)
- (4)
- (2)
- (1)
- (30)
- (1)
- (323)
- (642)
- (2)
- (53)
- (31)
- (16)
- (3)
- (1)
- (93,968)
- (3)
Filtered Search Results

Content And Storage | Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. |
---|---|
Target Species | Human |
Host Species | Rabbit |
Conjugate | Unconjugated |
Applications | Immunocytochemistry,Western Blot |
Form | Liquid |
Isotype | IgG |
Gene Accession No. | P68431, Q71DI3 |
Concentration | 0.5 mg/mL |
Antigen | H3K27me2 |
Gene Symbols | H3C1, H3C10, H3C12, H3C14, H3C15, H3C2, H3C7 |
Regulatory Status | RUO |
Purification Method | Affinity chromatography |
Gene Alias | dimethyl H3; di-methyl H3; Dimethyl Histone H3; di-methyl histone H3; Di-Methyl-H3 K27; Di-Methyl-H3 Lys27; Di-Methyl-Histone H3 K27; Di-Methyl-Histone H3 Lys27; Di-Tri-Methyl-Histone H3 K27; Di-Tri-Methyl-Histone H3 Lys27; H3; H3 histone; H3 histone family, member A; H3 histone family, member I; H3 histone family, member K; H3 histone family, member L; H3 histone family, member M; H3 histone, family 2; H3 histone, family 3A; H3 histone, family 3B; H3 histone, family 3B (H3.3B); H3 histone, family 3B.1; H3 histone, family 3C; H3 K27me2; H3.1-221; H3.1-291; H3.1-I; H3.2; H3.2-221; H3.2-614; H3.2-615; H3.2-616; H3.3A; H3.3B; H3.5; H3/A; H3/b; H3/d; H3/f; H3/i; H3/j; H3/k; H3/l; H3/M; H3/n; H3/o; H3-143; H3-291; H3-3A; H3-3B; h3-5; H3-53; H3-614; H3a; H3b; H3-B; H3C1; H3c10; H3c11; H3C12; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3f; H3-F; H3F1K; H3F2; H3F3; h3f3a; H3F3B; h3f3b.1; h3f3c; h3f3d; H3FA; H3FB; H3FC HIST1H3C; H3FD; H3FF; H3FH; H3FI; H3FJ; H3FK; H3FL; H3FM; H3FN; H3g; H3h; H3i; H3k27; H3K27me2/3; H3K27me2me3; H3Lys27me2; H3Lys27me2/3; H3Lys27me2me3; Hist1; HIST1H3A; HIST1H3B; Hist1h3c; HIST1H3D; Hist1h3e; HIST1H3F; Hist1h3g; HIST1H3H; HIST1H3I; HIST1H3J; HIST2H3A; Hist2h3b; HIST2H3C; Hist2h3c1; Hist2h3c2; Hist2h3c2-ps; Hist2h3ca1; Hist2h3ca2; HIST2H3D; histone 1, H3a; histone 1, H3b; histone 1, H3f; histone 1, H3h; histone 2, H3a; histone 2, H3c; histone 2, H3c2; histone 2, H3ca2; Histone 3; histone cluster 1, H3a; histone cluster 1, H3b; histone cluster 1, H3f; histone cluster 1, H3h; histone cluster 2, H3a; histone cluster 2, H3c; histone cluster 2, H3c2; histone cluster 2, H3c2, pseudogene; histone gene complex 1; histone H3; histone H3.1; Histone H3.2; histone H3.3; Histone H3.3C; histone H3.5; Histone H3/a; Histone H3/b; Histone H3/c; Histone H3/d; Histone H3/f; Histone H3/h; Histone H3/i; Histone H3/j; Histone H3/k; histone H3/l; Histone H3/m; histone H3/o; Histone H3K27; Histone H3K27me2; histone variant H3.5; hypothetical protein LOC550262; M32461; methyl Histone 3; methyl Histone H3; PP781; wu:fa25h06; wu:fa96g06; wu:fb07a08; wu:fb36f01; zgc:110292; zgc:174300; zgc:56193; zgc:56418; zgc:64222; zgc:86731 |
Gene | H3C15 |
Product Type | Antibody |
Gene ID (Entrez) | 126961, 333932, 8350, 8356, 8357, 8358, 8968 |
Formulation | PBS with 0.1% BSA, 30% glycerol and 0.09% sodium azide; pH 7.2 |
Classification | Polyclonal |
Primary or Secondary | Primary |
CHD4 Recombinant Human Monoclonal Antibody (K49015_15E2), Invitrogen™
Human Recombinant Monoclonal Antibody
Content And Storage | Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. |
---|---|
Target Species | Human |
Host Species | Human |
Conjugate | Unconjugated |
Applications | ELISA,Western Blot |
Form | Liquid |
Isotype | IgG1 |
Gene Accession No. | Q14839 |
Concentration | 1 mg/mL |
Antigen | CHD4 |
Regulatory Status | RUO |
Purification Method | Protein A |
Gene Alias | 9530019N15Rik; AA617397; ATP-dependent helicase CHD4; BC005710; Chd4; CHD-4; chromodomain helicase DNA binding protein 4; chromodomain-helicase-DNA-binding protein 4; D6Ertd380e; Mi-2; Mi-2 autoantigen; Mi-2 autoantigen 218 kDa protein; Mi-2 beta; MI2B; Mi-2b; Mi-2beta; Mi2-BETA; mKIAA4075 |
Gene | CHD4 |
Product Type | Antibody |
Gene ID (Entrez) | 1108 |
Formulation | PBS with 0.09% sodium azide |
Immunogen | Recombinant human CHD4 (immunogen range is 1291-1550). |
Classification | Recombinant Monoclonal |
Primary or Secondary | Primary |
Clone | K49015_15E2 |
Content And Storage | Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. |
---|---|
Target Species | Human,Mouse |
Host Species | Mouse |
Conjugate | Unconjugated |
Applications | Western Blot |
Form | Liquid |
Isotype | IgG1 |
Gene Accession No. | P21246, P63089 |
Concentration | 1 mg/mL |
Antigen | Pleiotrophin |
Regulatory Status | RUO |
Purification Method | Protein A |
Gene Alias | HARP; HBBM; HBBN; HB-GAM; HBGF8; HBGF-8; HBNF; HBNF1; HBNF-1; heparin affin regulatory peptide; heparin affin regulatory protein; heparin binding factor; heparin-binding brain mitogen; Heparin-binding growth factor 8; heparin-binding growth-associated molecule; heparin-binding neurite outgrowth promoting factor; Heparin-binding neurite outgrowth-promoting factor; Heparin-binding neurite outgrowth-promoting factor 1; heparin-binding neurite promoting factor; heparin-binding neurotorphic factor; heparin-binding neutrophic factor; NEGF1; OSF; Osf1; OSF-1; osteoblastic cell factor; Osteoblast-specific factor 1; pleiotrophin; pleiotrophin (heparin binding growth factor 8, neurite growth-promoting factor 1); Pleiotrophin (Heparine binding factor, Hbnf, in the mouse); PTN |
Gene | PTN |
Product Type | Antibody |
Gene ID (Entrez) | 19242, 5764 |
Formulation | PBS with 0.09% sodium azide |
Immunogen | Recombinant human PTN (proprietary range information). |
Classification | Monoclonal |
Primary or Secondary | Primary |
Clone | K06279_4G7 |
Content And Storage | -20°C |
---|---|
Target Species | Human |
Host Species | Rabbit |
Conjugate | Biotin |
Applications | ELISA,Western Blot |
Form | Lyophilized |
Gene Accession No. | P09603 |
Concentration | 0.1-1.0 mg/mL |
Antigen | M-CSF |
Gene Symbols | Csf1 |
Regulatory Status | RUO |
Purification Method | Antigen affinity chromatography |
Gene Alias | C87615; colony stimulating factor 1; colony stimulating factor 1 (macrophage); colony-stimulating factor-1 splice variant; CSF1; CSF-1; Csfm; H-MCSF; lanimostim; macrophage colony stimulating factor 1; macrophage colony stimulating factor alpha; macrophage colony stimulating factor beta; macrophage colony-stimulating factor; macrophage colony-stimulating factor 1; macrophage colony-stimulating factor beta; macrophage-colony stimulating factor alpha; MCSF; MCSF alpha; MCSFBETA; MGC31930; M-MCSF; op; osteopetrosis; Processed macrophage colony-stimulating factor 1 |
Gene | Csf1 |
Gene ID (Entrez) | 1435 |
Formulation | PBS with no preservative |
Immunogen | E.coli-derived Recombinant Human M-CSF |
Classification | Polyclonal |
Primary or Secondary | Primary |
CD8 alpha Monoclonal Antibody (C8/144B), Alexa Fluor™ Plus 488, Invitrogen™
Mouse Monoclonal Antibody
Content And Storage | 4° C, store in dark |
---|---|
Target Species | Human |
Host Species | Mouse |
Conjugate | Alexa Fluor Plus 488 |
Applications | Immunohistochemistry (Paraffin) |
Form | Liquid |
Gene Accession No. | P01732, P10966 |
Isotype | IgG1 κ |
Concentration | 0.2 mg/mL |
Antigen | CD8 alpha |
Regulatory Status | RUO |
Purification Method | Affinity chromatography |
Gene Alias | BB154331; CD8; CD8 alpha; CD8 alpha chain; CD8 alpha chain precursor; CD8 antigen; CD8 antigen 32 kDa chain; CD8 antigen 37 kDa chain; CD8 antigen alpha polypeptide; CD8 antigen alpha protein; CD8 antigen alpha protein precursor; CD8 antigen alpha-chain; CD8 antigen beta polypeptide; CD8 antigen beta polypeptide precursor; CD8 antigen beta-chain; CD8 antigen, alpha chain; CD8 antigen, alpha polypeptide; CD8 antigen, alpha polypeptide (p32); CD8 antigen, alpha-chain; CD8 antigen, beta chain; CD8 antigen, beta chain 1; CD8 antigen, beta polypeptide; CD8 antigen, beta polypeptide 1 (p37); CD8 antigen, beta-chain; CD8 beta; CD8 beta chain; CD8 beta-2; CD8a; CD8A antigen alpha; CD8a molecule; CD8A; T-cell surface glycoprotein; CD8alpha; CD8B; CD8b antigen; CD8b molecule; CD8b molecule pseudogene; Cd8b1; CD8beta; CD8BP; fCD8; LEU2; Leu-2; Leu2 T-lymphocyte antigen; leu-2a; Ly-2; LY3; Ly-3; Ly-35; Ly-B; Ly-C; Lymphocyte antigen 3; Lyt2; Lyt-2; Lyt-2.1 lymphocyte differentiation antigen (AA at 100); Lyt3; Lyt-3; MAL; membrane glycoprotein; membrane protein; OKT8 T-cell antigen; OX-8 membrane antigen; p32; P37; RHACD8-4; T cell co-receptor; T lymphocyte surface glycoprotein beta chain; T8 T-cell antigen; T-cell antigen Leu2; T-cell membrane glycoprotein Ly-3; T-cell surface glycoprotein; T-cell surface glycoprotein CD8 alpha chain; T-cell surface glycoprotein CD8 beta chain; T-cell surface glycoprotein Lyt-2; T-cell surface glycoprotein Lyt-3; T-cell surface molecule; T-lymphocyte differentiation antigen T8/Leu-2; type I transmembrane glycoprotein |
Gene | CD8B |
Gene ID (Entrez) | 925, 926 |
Formulation | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
Immunogen | A 13 amino acid synthetic peptide from the C-terminal cytoplasmic domain of alpha chain of human CD8 molecule |
Classification | Monoclonal |
Clone | C8/144B |
Content And Storage | 4° C, store in dark |
---|---|
Target Species | Human |
Host Species | Rat |
Conjugate | Alexa Fluor 514 |
Applications | Immunohistochemistry (Paraffin) |
Form | Liquid |
Gene Accession No. | P46013 |
Isotype | IgG2a κ |
Concentration | 0.2 mg/mL |
Antigen | Ki-67 |
Regulatory Status | RUO |
Purification Method | Affinity chromatography |
Gene Alias | antigen identified by monoclonal antibody Ki 67; antigen identified by monoclonal antibody Ki-67; Antigen identified by monoclonal antibody Ki-67 homolog; Antigen KI-67; Antigen KI-67 homolog; antigen KI-67; proliferation marker protein Ki-67; antigen KI-67-like; cb31; D630048A14Rik; I79_022666; Ki67; Ki-67; KIA; LOW QUALITY PROTEIN: proliferation marker protein Ki-67; marker of proliferation Ki-67; MIB-; MIB-1; Mki67; PPP1R105; Proliferation marker protein Ki-67; proliferation-related Ki-67 antigen; protein phosphatase 1, regulatory subunit 105; RP11-380J17.2; sb:cb31; si:ch211-250b22.7; unnamed protein product; wu:fa11g09; wu:fb57a07; wu:fi14e05 |
Gene | Mki67 |
Gene ID (Entrez) | 4288 |
Formulation | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
Classification | Monoclonal |
Clone | SolA15 |
CD8 alpha Monoclonal Antibody (C8/144B), Alexa Fluor™ Plus 555, Invitrogen™
Mouse Monoclonal Antibody
Content And Storage | 4° C, store in dark |
---|---|
Target Species | Human |
Host Species | Mouse |
Conjugate | Alexa Fluor Plus 555 |
Applications | Immunohistochemistry (Paraffin) |
Form | Liquid |
Gene Accession No. | P01732, P10966 |
Isotype | IgG1 κ |
Concentration | 0.2 mg/mL |
Antigen | CD8 alpha |
Regulatory Status | RUO |
Purification Method | Affinity chromatography |
Gene Alias | BB154331; CD8; CD8 alpha; CD8 alpha chain; CD8 alpha chain precursor; CD8 antigen; CD8 antigen 32 kDa chain; CD8 antigen 37 kDa chain; CD8 antigen alpha polypeptide; CD8 antigen alpha protein; CD8 antigen alpha protein precursor; CD8 antigen alpha-chain; CD8 antigen beta polypeptide; CD8 antigen beta polypeptide precursor; CD8 antigen beta-chain; CD8 antigen, alpha chain; CD8 antigen, alpha polypeptide; CD8 antigen, alpha polypeptide (p32); CD8 antigen, alpha-chain; CD8 antigen, beta chain; CD8 antigen, beta chain 1; CD8 antigen, beta polypeptide; CD8 antigen, beta polypeptide 1 (p37); CD8 antigen, beta-chain; CD8 beta; CD8 beta chain; CD8 beta-2; CD8a; CD8A antigen alpha; CD8a molecule; CD8A; T-cell surface glycoprotein; CD8alpha; CD8B; CD8b antigen; CD8b molecule; CD8b molecule pseudogene; Cd8b1; CD8beta; CD8BP; fCD8; LEU2; Leu-2; Leu2 T-lymphocyte antigen; leu-2a; Ly-2; LY3; Ly-3; Ly-35; Ly-B; Ly-C; Lymphocyte antigen 3; Lyt2; Lyt-2; Lyt-2.1 lymphocyte differentiation antigen (AA at 100); Lyt3; Lyt-3; MAL; membrane glycoprotein; membrane protein; OKT8 T-cell antigen; OX-8 membrane antigen; p32; P37; RHACD8-4; T cell co-receptor; T lymphocyte surface glycoprotein beta chain; T8 T-cell antigen; T-cell antigen Leu2; T-cell membrane glycoprotein Ly-3; T-cell surface glycoprotein; T-cell surface glycoprotein CD8 alpha chain; T-cell surface glycoprotein CD8 beta chain; T-cell surface glycoprotein Lyt-2; T-cell surface glycoprotein Lyt-3; T-cell surface molecule; T-lymphocyte differentiation antigen T8/Leu-2; type I transmembrane glycoprotein |
Gene | Cd8a |
Gene ID (Entrez) | 925, 926 |
Formulation | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
Immunogen | A 13 amino acid synthetic peptide from the C-terminal cytoplasmic domain of alpha chain of human CD8 molecule |
Classification | Monoclonal |
Clone | C8/144B |
Cytokeratin Pan Type I/II Antibody Cocktail, Alexa Fluor™ Plus 555, Invitrogen™
Mouse Cocktail Antibody
Content And Storage | 4° C, store in dark |
---|---|
Target Species | Human |
Host Species | Mouse |
Conjugate | Alexa Fluor Plus 555 |
Applications | Immunohistochemistry (Paraffin) |
Form | Liquid |
Gene Accession No. | P02533, P02538, P04264, P05783, P05787, P08727, P08729, P08779, P12035, P13645, P13646, P13647, P19012, P19013, P35908, Q01546, Q04695, Q7Z794 |
Isotype | IgG1 |
Concentration | 0.2 mg/mL |
Antigen | Cytokeratin Pan Type I/II |
Regulatory Status | RUO |
Purification Method | Affinity chromatography |
Gene Alias | 2310016L08Rik; 3300001P10Rik; 39.1; 40-kDa keratin intermediate filament; 47 kDa cytokeratin; 56 kDa cytokeratin; 57kd keratin; 57kDa keratin; 58 kDa cytokeratin; 60-kDa keratin; 63kDa Keratin; 65 kDa cytokeratin; 67 kDa cytokeratin; AA960620; adult keratin; AI324768; AI528832; AI626930; AI663979; AL022697; alpha keratin; AU019895; AW108092; AW146334; basic epidermal type II cytokeratin (carboxy-terminal region, clone pUF164); BB005427; BCIE; BIE; Card2; cell proliferation-inducing gene 46 protein; CK 2e; CK1; CK-1; CK10; CK-10; CK13; CK-13; CK14; CK-14; CK15; CK-15; CK16; CK-16; CK-17; CK18; CK-18; CK19; CK-19; CK-1B; CK-2e; CK3; CK-3; CK4; CK-4; CK5; CK-5; ck55; CK6A; CK-6A; CK6C; CK-6C; CK6D; CK-6D; CK-6E; CK7; CK-7; CK8; CK-8; CYK18; CYK4; CYK8; CYKER; cytokeratin 1; cytokeratin 10; cytokeratin 13; cytokeratin 14; cytokeratin 15; cytokeratin 16; cytokeratin 18; cytokeratin 19; cytokeratin 3; cytokeratin 4; cytokeratin 5; cytokeratin 6A; cytokeratin 6C; cytokeratin 6D; cytokeratin 7; cytokeratin 8; cytokeratin 8 (370 AA); cytokeratin endo A; Cytokeratin endo B; cytokeratin otokeratin; cytokeratin type II; cytokeratin type II, component Ib/c; cytokeratin type II, component III; cytokeratin VIB; cytokeratin VII; cytokeratin-1; Cytokeratin-10; cytokeratin-13; Cytokeratin-14; cytokeratin-15; Cytokeratin-16; cytokeratin-17; Cytokeratin-18; cytokeratin-19; Cytokeratin-1B; Cytokeratin-2e; cytokeratin-3; Cytokeratin-4; cytokeratin-5; Cytokeratin-6A; cytokeratin-6B; cytokeratin-6C; Cytokeratin-6D; cytokeratin-6E; cytokeratin-7; Cytokeratin-8; cytokeratin-A; Cytoskeletal 57 kDa keratin; D130054E02Rik; D15Wsu77e; DDD; DDD1; ear specific cytokeratin; EBS2; ebs3; ebs4; EGK_03684; EGK_03685; EHK; EHK1; Endo B; EndoA; EndoC; epidermal keratin 10; epidermal keratin VII; epidermolysis bullosa simplex 2 Dowling-Meara/Kobner/Weber-Cockayne types; epidermolysis bullosa simplex, Dowling-Meara, Koebner; epidermolytic hyperkeratosis 1; epidermolytic hyperkeratosis; keratosis palmaris et plantaris; epithelial keratin 1; epithelial keratin 10; epithelial keratin 2e; Epithelial keratin-1; Epithelial keratin-2e; EPPK; fgk; fin and gill keratin; FNEPPK; focal non-epidermolytic palmoplantar keratoderma; GK-19; Hair alpha protein; HMWCK; Hom s 5; I79_019823; I79_021074; I79_023185; I79_024335; intermediate filament protein; K1; K10; K13; K14; K15; K16; K17; K18; K19; K1B; K1C1; K1CO; K1CP; K1CS; K2C7; K2C8; K2e; K3; K3 keratin; K4; K5; K6A; K6a keratin; K6C; K6D; K7; K77; K8; Ka10; Ka13; Ka14; Ka15; Ka16; Ka17; Ka19; kamp-keratin derived antimicrobial peptide; Kb1; Kb2; Kb4; Kb7; KDAMP; KER1; Ker10; Ker2; KERA; keratin; keratin 1; keratin 1 (epidermolytic hyperkeratosis); keratin 1, type II; keratin 10; keratin 10 (epidermolytic hyperkeratosis); keratin 10 (epidermolytic hyperkeratosis; keratosis palmaris et plantaris); keratin 10, type I; keratin 10, type I L homeolog; keratin 10, type I S homeolog; keratin 12, gene 2 S homeolog; keratin 13; keratin 13, type I; keratin 13, type I S homeolog; keratin 14; keratin 14 (epidermolysis bullosa simplex, Dowling-Meara, Koebner); keratin 14, type I; keratin 14, type I L homeolog; keratin 15; keratin 15, gene 1 S homeolog; keratin 15, type I; keratin 16; keratin 16 (focal non-epidermolytic palmoplantar keratoderma); keratin 16, type I; keratin 16, type I S homeolog; keratin 17; keratin 17 L homeolog; keratin 17, type I; keratin 17, type I L homeolog; keratin 18; keratin 18, type I; keratin 19; keratin 19 S homeolog; keratin 19 S homeolog; keratin 19; keratin 19, type I; Keratin 1B; keratin 2; keratin 2 (epidermal ichthyosis bullosa of Siemens); keratin 2 epidermis; keratin 2, type II; keratin 24; keratin 2A; keratin 2A (epidermal ichthyosis bullosa of Siemens); keratin 3; keratin 3, type II; keratin 4; keratin 4, type II; keratin 5; keratin 5 (epidermolysis bullosa simplex Dowling-Meara/Kobner/Weber-Cockayne types); keratin 5 (epidermolysis bullosa simplex, Dowling-Meara/Kobner/Weber-Cockayne types) |
Gene | Krt6a |
Gene ID (Entrez) | 374454, 3848, 3849, 3850, 3851, 3852, 3853, 3855, 3856, 3858, 3860, 3861, 3866, 3868, 3872, 3875, 3880, 51350 |
Formulation | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
Immunogen | Human epidermal keratin |
Classification | Cocktail |
Clone | AE1/AE3 |
Content And Storage | 4° C, store in dark |
---|---|
Target Species | Human |
Host Species | Mouse |
Conjugate | Alexa Fluor Plus 555 |
Applications | Immunohistochemistry (Paraffin) |
Form | Liquid |
Gene Accession No. | P01730 |
Isotype | IgG2b κ |
Concentration | 0.2 mg/mL |
Antigen | CD4 |
Regulatory Status | RUO |
Purification Method | Affinity chromatography |
Gene Alias | Activation B7-1 antigen; B7; B7.1; B7-1; BB1; B-lymphocyte activation antigen B7; CD28LG; CD28LG1; CD4; CD4 antigen; CD4 antigen (p55); CD4 antigen p55; Cd4 molecule; CD4 precursor; CD4 receptor; CD4, allele 1; cd4a; CD4mut; CD80; CD80 antigen (CD28 antigen ligand 1, B7-1 antigen); CD80 molecule; cell surface glycoprotein CD4; costimulatory factor CD80; costimulatory molecule variant IgV-CD80; CTLA-4 counter-receptor B7.1; fCD4; L3T4; LAB7; Leu-3; Ly-4; lymphocyte antigen CD4; lymphocyte antigen CD4 precursor; membrane protein; p55; T-cell differentiation antigen L3T4; T-cell surface antigen T4/Leu-3; T-cell surface glycoprotein CD4; T-cell surface glycoprotein CD4 precursor (T-cell surface antigen T4/Leu-3) (T-cell differentiation antigen L3T4); T-lymphocyte activation antigen CD80; W3/25; W3/25 antigen |
Gene | CD4 |
Gene ID (Entrez) | 920 |
Formulation | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
Classification | Monoclonal |
Clone | N1UG0 |
CD8 alpha Monoclonal Antibody (C8/144B), Alexa Fluor™ Plus 647, Invitrogen™
Mouse Monoclonal Antibody
Content And Storage | 4° C, store in dark |
---|---|
Target Species | Human |
Host Species | Mouse |
Conjugate | Alexa Fluor Plus 647 |
Applications | Immunohistochemistry (Paraffin) |
Form | Liquid |
Gene Accession No. | P01732, P10966 |
Isotype | IgG1 κ |
Concentration | 0.2 mg/mL |
Antigen | CD8 alpha |
Regulatory Status | RUO |
Purification Method | Affinity chromatography |
Gene Alias | BB154331; CD8; CD8 alpha; CD8 alpha chain; CD8 alpha chain precursor; CD8 antigen; CD8 antigen 32 kDa chain; CD8 antigen 37 kDa chain; CD8 antigen alpha polypeptide; CD8 antigen alpha protein; CD8 antigen alpha protein precursor; CD8 antigen alpha-chain; CD8 antigen beta polypeptide; CD8 antigen beta polypeptide precursor; CD8 antigen beta-chain; CD8 antigen, alpha chain; CD8 antigen, alpha polypeptide; CD8 antigen, alpha polypeptide (p32); CD8 antigen, alpha-chain; CD8 antigen, beta chain; CD8 antigen, beta chain 1; CD8 antigen, beta polypeptide; CD8 antigen, beta polypeptide 1 (p37); CD8 antigen, beta-chain; CD8 beta; CD8 beta chain; CD8 beta-2; CD8a; CD8A antigen alpha; CD8a molecule; CD8A; T-cell surface glycoprotein; CD8alpha; CD8B; CD8b antigen; CD8b molecule; CD8b molecule pseudogene; Cd8b1; CD8beta; CD8BP; fCD8; LEU2; Leu-2; Leu2 T-lymphocyte antigen; leu-2a; Ly-2; LY3; Ly-3; Ly-35; Ly-B; Ly-C; Lymphocyte antigen 3; Lyt2; Lyt-2; Lyt-2.1 lymphocyte differentiation antigen (AA at 100); Lyt3; Lyt-3; MAL; membrane glycoprotein; membrane protein; OKT8 T-cell antigen; OX-8 membrane antigen; p32; P37; RHACD8-4; T cell co-receptor; T lymphocyte surface glycoprotein beta chain; T8 T-cell antigen; T-cell antigen Leu2; T-cell membrane glycoprotein Ly-3; T-cell surface glycoprotein; T-cell surface glycoprotein CD8 alpha chain; T-cell surface glycoprotein CD8 beta chain; T-cell surface glycoprotein Lyt-2; T-cell surface glycoprotein Lyt-3; T-cell surface molecule; T-lymphocyte differentiation antigen T8/Leu-2; type I transmembrane glycoprotein |
Gene | Cd8a |
Gene ID (Entrez) | 925, 926 |
Formulation | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
Immunogen | A 13 amino acid synthetic peptide from the C-terminal cytoplasmic domain of alpha chain of human CD8 molecule |
Classification | Monoclonal |
Clone | C8/144B |
CD8 alpha Monoclonal Antibody (C8/144B), Alexa Fluor™ Plus 594, Invitrogen™
Mouse Monoclonal Antibody
Content And Storage | 4° C, store in dark |
---|---|
Target Species | Human |
Host Species | Mouse |
Conjugate | Alexa Fluor Plus 594 |
Applications | Immunohistochemistry (Paraffin) |
Form | Liquid |
Gene Accession No. | P01732, P10966 |
Isotype | IgG1 κ |
Concentration | 0.2 mg/mL |
Antigen | CD8 alpha |
Regulatory Status | RUO |
Purification Method | Affinity chromatography |
Gene Alias | BB154331; CD8; CD8 alpha; CD8 alpha chain; CD8 alpha chain precursor; CD8 antigen; CD8 antigen 32 kDa chain; CD8 antigen 37 kDa chain; CD8 antigen alpha polypeptide; CD8 antigen alpha protein; CD8 antigen alpha protein precursor; CD8 antigen alpha-chain; CD8 antigen beta polypeptide; CD8 antigen beta polypeptide precursor; CD8 antigen beta-chain; CD8 antigen, alpha chain; CD8 antigen, alpha polypeptide; CD8 antigen, alpha polypeptide (p32); CD8 antigen, alpha-chain; CD8 antigen, beta chain; CD8 antigen, beta chain 1; CD8 antigen, beta polypeptide; CD8 antigen, beta polypeptide 1 (p37); CD8 antigen, beta-chain; CD8 beta; CD8 beta chain; CD8 beta-2; CD8a; CD8A antigen alpha; CD8a molecule; CD8A; T-cell surface glycoprotein; CD8alpha; CD8B; CD8b antigen; CD8b molecule; CD8b molecule pseudogene; Cd8b1; CD8beta; CD8BP; fCD8; LEU2; Leu-2; Leu2 T-lymphocyte antigen; leu-2a; Ly-2; LY3; Ly-3; Ly-35; Ly-B; Ly-C; Lymphocyte antigen 3; Lyt2; Lyt-2; Lyt-2.1 lymphocyte differentiation antigen (AA at 100); Lyt3; Lyt-3; MAL; membrane glycoprotein; membrane protein; OKT8 T-cell antigen; OX-8 membrane antigen; p32; P37; RHACD8-4; T cell co-receptor; T lymphocyte surface glycoprotein beta chain; T8 T-cell antigen; T-cell antigen Leu2; T-cell membrane glycoprotein Ly-3; T-cell surface glycoprotein; T-cell surface glycoprotein CD8 alpha chain; T-cell surface glycoprotein CD8 beta chain; T-cell surface glycoprotein Lyt-2; T-cell surface glycoprotein Lyt-3; T-cell surface molecule; T-lymphocyte differentiation antigen T8/Leu-2; type I transmembrane glycoprotein |
Gene | CD8B |
Gene ID (Entrez) | 925, 926 |
Formulation | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
Immunogen | A 13 amino acid synthetic peptide from the C-terminal cytoplasmic domain of alpha chain of human CD8 molecule |
Classification | Monoclonal |
Clone | C8/144B |
Content And Storage | 4° C, store in dark |
---|---|
Target Species | Human |
Host Species | Mouse |
Conjugate | Alexa Fluor Plus 594 |
Applications | Immunohistochemistry (Paraffin) |
Form | Liquid |
Gene Accession No. | P18827 |
Isotype | IgG1 κ |
Concentration | 0.2 mg/mL |
Antigen | CD138 |
Regulatory Status | RUO |
Purification Method | Protein A |
Gene Alias | AA408134; AA409076; CD antigen 138; CD138; CD138 antigen; heparan sulfate proteoglycan fibroblast growth factor receptor; HSPG; sCD138; SDC; Sdc1; soluble CD138; Sstn; syn-1; Synd; SYND1; Synd-1; SYNDECA; syndecan; syndecan 1; syndecan proteoglycan 1; Syndecan1; syndecan-1; synstatin |
Gene | Sdc1 |
Gene ID (Entrez) | 6382 |
Formulation | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
Immunogen | A mixture of U266 and XG-1 human myeloma cell lines |
Classification | Monoclonal |
Clone | MI15 |
Content And Storage | 4° C, store in dark |
---|---|
Target Species | Human |
Host Species | Mouse |
Conjugate | Alexa Fluor Plus 594 |
Applications | Immunohistochemistry (Paraffin) |
Form | Liquid |
Gene Accession No. | P01903, P01911, P04233, P13762, P79483, Q30154 |
Isotype | IgG2b κ |
Concentration | 0.2 mg/mL |
Antigen | HLA-DR |
Regulatory Status | RUO |
Purification Method | Affinity chromatography |
Gene Alias | AI323765; BLA-DRB3; BOLA-DRA; BoLA-DR-alpha; BoLA-DRB; BOLA-DRB3; BoLA-DRB3 protein; BoLA-DRB3.2; Bota-DRB01; Bota-DRB02; Bota-DRB04; Bota-DRB07; Bota-DRB21; Bota-DRB22; bovine leukocyte antigen; Cd74; CD74 antigen; CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated); CD74 molecule; Cd74 molecule, major histocompatibility complex, class II invariant chain; class II-associated invariant chain peptide; CLIP; Clone P2-beta-3; DASS-397D15.1; DHLAG; dinucleotide microsatellite; DLA class II histocompatibility antigen, DR-1 beta chain; DLA DRBB1 beta chain; DLA-DR beta; DLA-DRB1; DLA-DRBB1; DR beta-5; DR beta-chain antigen binding domain; DR-16; DR2-beta-2; DR4; DR-4; DR7; DR9; DR-9; DRB; DRB1; DRB1 transplantation antigen; DRB3; DRB4; DRBB1; DR-beta chain; DR-beta chain MHC class II; DRw10; Dw2; DW2.2/DR2.2; E-alpha-f; FLJ51114; FLJ75017; FLJ76359; gamma chain of class II antigens; H-2 class II histocompatibility antigen gamma chain; H-2 class II histocompatibility antigen, E-D alpha chain; H-2 class II histocompatibility antigen, E-K alpha chain; H-2 class II histocompatibility antigen, E-U alpha chain; H-2Ea; H2-Ea; H2-Ea-ps; H2-IE-alpha; histocompatibility 2, class II antigen E alpha; histocompatibility 2, class II antigen E alpha, pseudogene; histocompatibility antigen HLA-DR alpha; histocompatibility complex, class II, DR beta 3; histocompatibility: class II antigens, gamma chain of; HLA class II histocompatibility antigen gamma chain; HLA class II histocompatibility antigen, DR alpha chain; HLA class II histocompatibility antigen, DR beta 3 chain; HLA class II histocompatibility antigen, DR beta 4 chain; HLA class II histocompatibility antigen, DR beta 5 chain; HLA class II histocompatibility antigen, DR-1 beta chain; HLA class II histocompatibility antigen, DR-5 beta chain; HLA class II histocompatibility antigen, DRB1-15 beta chain; HLA class II histocompatibility antigen, DRB1-16 beta chain; HLA class II histocompatibility antigen, DRB1-3 chain; HLA class II histocompatibility antigen, DRB1-7 beta chain; HLA class II histocompatibility antigen, DRB1-9 beta chain; HLADG; HLA-DR antigens-associated invariant chain; HLA-DR1B; HLA-DR3B; HLA-DR4B; HLA-DRA; HLA-DRA1; HLA-DRB; HLA-DRB1; HLA-DRB2; HLA-DRB3; HLA-DRB4; HLA-DRB5; HLA-DR-gamma; human leucocyte antigen DRB1; human leucocyte antigen DRB3; human leucocyte antigen DRB4; human leucocyte antigen DRB5; ia antigen-associated invariant chain; Ia3; Ia-3; Ia-associated invariant chain; Ia-GAMMA; I-E alpha MHC class II; I-Ealpha; II; integral membrane glycoprotein; invariant gamma chain; invariant polypeptide of major histocompatibility complex, class II antigen-associated; INVG34; LA-DRB; leukocyte antigen; leukocyte antigen class II; leukocyte antigen DRB3; lymphocyte antigen DRB1; major histocompatibility complex class II DR-beta chain; major histocompatibility complex, class II, DR alpha; major histocompatibility complex, class II, DR alpha precursor; major histocompatibility complex, class II, DR beta 1; major histocompatibility complex, class II, DR beta 3; major histocompatibility complex, class II, DR beta 4; major histocompatibility complex, class II, DR beta 4 precursor; major histocompatibility complex, class II, DR beta 5; major histocompatibility complex, class II, DRB3; MHC cell surface glycoprotein; MHC class I antigen; MHC class II antigen; MHC class II antigen beta chain; MHC class II antigen BoLA-DRB3; MHC class II antigen DR beta 3 chain; MHC class II antigen DRA; MHC class II antigen DRB1*15; MHC class II antigen DRB1*16; MHC class II antigen DRB1*3; MHC class II antigen DRB1*9; MHC class II antigen DRB3; MHC class II antigen DRB4; MHC class II antigen DRB5; MHC class II antigen E alpha; MHC class II antigen HLA-DR-beta; MHC class II DLA DRB1 beta chain; MHC class II DLA-DRB; MHC class II DLA-DR-beta-1; MHC class II DR beta 1; MHC class II DR beta chain |
Gene | HLA-DRB3 |
Gene ID (Entrez) | 3122, 3123, 3125, 3126, 3127, 972 |
Formulation | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
Classification | Monoclonal |
Clone | LN3 |
Content And Storage | 4° C, store in dark |
---|---|
Target Species | Human |
Host Species | Mouse |
Conjugate | Alexa Fluor Plus 647 |
Applications | Immunohistochemistry (Paraffin) |
Form | Liquid |
Gene Accession No. | Q9BZS1 |
Isotype | IgG1 κ |
Concentration | 0.2 mg/mL |
Antigen | FOXP3 |
Regulatory Status | RUO |
Purification Method | Affinity chromatography |
Gene Alias | AIID; DIETER; forkhead box P3; forkhead box protein P3; Forkhead box protein P3 41 kDa form; Forkhead box protein P3, C-terminally processed; forkhead/winged helix transcription factor 3; Foxp3; FOXP3delta7; immune dysregulation, polyendocrinopathy, enteropathy, X-linked; immunodeficiency, polyendocrinopathy, enteropathy, X-linked; IPEX; JM2; MGC141961; MGC141963; PIDX; regulatory protein Foxp3; RGD1562112; RP23-54C14.1; scurfin; scurfy; sf; XPID |
Gene | Foxp3 |
Gene ID (Entrez) | 50943 |
Formulation | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
Classification | Monoclonal |
Clone | 236A/E7 |
Content And Storage | 4° C, store in dark |
---|---|
Target Species | Human |
Host Species | Mouse |
Conjugate | Alexa Fluor 420 |
Applications | Immunohistochemistry (Paraffin) |
Form | Liquid |
Gene Accession No. | P08670 |
Isotype | IgG1 κ |
Concentration | 0.2 mg/mL |
Antigen | Vimentin |
Regulatory Status | RUO |
Purification Method | Affinity chromatography |
Gene Alias | cb28; class-III intermediate microfilament; CTRCT30; epididymis luminal protein 113; FLJ36605; HEL113; intermediate filament; intermediate filament protein; RP11-124N14.1; similar to vimentin; VIM; VIME; Vimentin; vimentin C-terminus |
Gene | Vim |
Gene ID (Entrez) | 7431 |
Formulation | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
Classification | Monoclonal |
Clone | V9 |